The latest price target for Charles & Colvard (NASDAQ:CTHR) was reported by Roth Capital on September 3, 2021. The analyst firm set a price target for $3.75 expecting CTHR to rise to within 12 months (a possible 82.96% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Charles & Colvard (NASDAQ:CTHR) was provided by Roth Capital, and Charles & Colvard maintained their buy rating.

There is no last upgrade for Charles & Colvard

There is no last downgrade for Charles & Colvard.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Charles & Colvard, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Charles & Colvard was filed on September 3, 2021 so you should expect the next rating to be made available sometime around September 3, 2022.

While ratings are subjective and will change, the latest Charles & Colvard (CTHR) rating was a maintained with a price target of $3.50 to $3.75. The current price Charles & Colvard (CTHR) is trading at is $2.05, which is out of the analyst’s predicted range.